Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7969779 | 0.87 | — | — | |
| SCHEMBL2784206 | 0.78 | FTO (0.34) | FTO | |
| SCHEMBL332302 | 0.78 | FTO (0.36) | FTO | |
| SCHEMBL530116 | 0.75 | FTO (0.36) | FTO | |
| SCHEMBL3747895 | 0.73 | FTO (0.35) | FTO | |
| SCHEMBL4575132 | 0.71 | FTO (0.34) | FTO | |
| SCHEMBL8336070 | 0.70 | FTO (0.32) | FTO | |
| SCHEMBL4344779 | 0.68 | FTO (0.38) | FTO | |
| SCHEMBL1299465 | 0.65 | FTO (0.47) | FTO | |
| SCHEMBL29371871 | 0.65 | FTO (0.47) | FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170219585-A1 | ACTIVATION OF MYELOID-DERIVED SUPPRESSOR CELLS AS A PREDICTOR OF PATIENT RESPONSE TO INTERFERON-A THERAPY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2017-08-03 | — | — | US | claimed |
| US-20150064136-A1 | PREDICTORS OF PATIENT RESPONSE TO INTERFERON-A THERAPY | THE UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2015-03-05 | — | — | US | claimed |
| US-20240102074-A1 | SYSTEMS AND METHODS FOR PERFORMING ANTIMICROBIAL SUSCEPTIBILITY TESTING | SeLux Diagnostics, Inc. | 2024-03-28 | — | — | US | disclosed |
| EP-3570670-B1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL STORAGE DISEASES AND DISORDERS | CHILDRENS MEDICAL CENTER (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2024018415-A1 | USE OF 5-AMINOLEVULINIC ACID FOR THE TREATMENT OF THE PANCREATIC CANCER | VILLA, GIUSEPPE (IT) | 2024-01-25 | — | — | WO | disclosed |
| US-11845976-B2 | Systems and methods for performing antimicrobial susceptibility testing | SeLux Diagnostics, Inc. (US) | 2023-12-19 | — | — | US | disclosed |
| US-20230193341-A1 | EXPRESSION SYSTEMS, RECOMBINANT CELLS AND USES THEREOF | SELEXIS SA (CH) | 2023-06-22 | — | — | US | disclosed |
| EP-3443975-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEARING LOSS COMPRISING AVENANTHRAMIDE AS AN ACTIVE INGREDIENT | UNIV NAT CHONNAM IND FOUND (KR) | 2023-05-10 | — | — | EP | disclosed |
| US-11548936-B2 | Compositions and methods for treating lysosomal storage diseases and disorders | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2023-01-10 | — | — | US | disclosed |
| EP-4022079-A1 | SYSTEMS AND METHODS FOR PERFORMING ANTIMICROBIAL SUSCEPTIBILITY TESTING | Selux Diagnostics, Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| EP-3946736-A1 | SYSTEMS AND METHODS FOR METABOLIC ASSESSMENT UTILIZING 1-METHOXY-PMS | Selux Diagnostics Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| EP-1284739-A1 | COMPOSITION AND METHOD FOR INTERVENING NEURONAL DEATH USING SULFASALAZINE | Neurotech Co., Ltd. (KR) | 2003-02-26 | — | — | EP | disclosed |
| US-6521640-B1 | Method for interviewing neuronal death using sulfasalazine | NEUROTECH CO., LTD. (KR) | 2003-02-18 | — | — | US | disclosed |
| WO-2001075131-A9 | EXPRESSION OF UNCOUPLING PROTEIN (UCP) IN PLANTS | UNIV TECHNOLOGY CORP (US) | 2002-12-27 | — | — | WO | disclosed |
| US-20020197649-A1 | Catalytic amplification of multiplexed assay signals | MONOGRAM BIOSCIENCES, INC. | 2002-12-26 | — | — | US | disclosed |
| WO-2002097112-A2 | CATALYTIC AMPLIFICATION OF MULTIPLEXED ASSAY SIGNALS | ACLARA BIOSCIENCES, INC. (US) | 2002-12-05 | — | — | WO | disclosed |
| WO-2001075131-A2 | EXPRESSION OF UNCOUPLING PROTEIN (UCP) IN PLANTS | UNIVERSITY TECHNOLOGY CORPORATION (US) | 2001-10-11 | — | — | WO | disclosed |
| WO-2001072308-A1 | COMPOSITION AND METHOD FOR INTERVENING NEURONAL DEATH USING SULFASALAZINE | NEUROTECH CO., LTD. (KR) | 2001-10-04 | — | — | WO | disclosed |
| US-6229055-B1 | SYNTHESIS OF FLUORINATED RESORCINOL WHICH IS USEFUL IN THE PREPARATION OF FLUORINATED FLUORESCEIN AND RHODOL DYES SUITABLE FOR USE AS TRACERS, LABELS, OR INTERMEDIATES | MOLECULAR PROBES, INC. | 2001-05-08 | — | — | US | disclosed |
| US-6162931-A | Fluorinated xanthene derivatives | MOLECULAR PROBES, INC. (US) | 2000-12-19 | — | — | US | disclosed |